B
BBIO
Bridgebio Pharma
68.15
-0.41-0.60%After Hours: 68.16 +0.01 +0.01%19:48 10/26 EDT
OPEN/PREV CLOSE68.56/68.56
TODAY RANGE67.87-68.83
VOL2.06M
MARKET CAP13.32B
52 WEEK RANGE56.74-93.42
AVG VOL (3M)2.47M
% TURNOVER0.68%
TURNOVER--
P/E (TTM)-19.0977
% RANGE1.36%
EPS(TTM)-3.5685
P/E(FORWARD)-24.8882
P/B-5.2912
BVPS-12.8798
DIVIDEND--
P/S26.44
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP12.13B
SHARES OUTSTANDING195.49M
NEXT EARNINGS10/27-11/02
FREE FLOAT178.03M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·15h ago
Alnylam: Amvuttra Growth And Brezosiran Strengthen The Bull Case
TipRanks·15h ago
BridgeBio Pharma (BBIO) Receives a Buy from Cantor Fitzgerald
Simply Wall St·3d ago
How Investors May Respond To BridgeBio Pharma (BBIO) Positive Drug Data
Dow Jones·5d ago
BridgeBio Pharma Is Maintained at Overweight by Morgan Stanley
Simply Wall St·6d ago
BridgeBio Pharma (BBIO) Advances Late Stage Programs, Is The Valuation Still Pricey?
Dow Jones·10/19 20:59
BridgeBio Pharma Price Target Cut to $91.00/Share From $94.00 by Citigroup
Dow Jones·10/19 20:59
BridgeBio Pharma Is Maintained at Neutral by Citigroup
Benzinga·10/19 20:49
Citigroup Maintains Neutral on BridgeBio Pharma, Lowers Price Target to $91
Dow Jones·10/19 16:31
BridgeBio Pharma Price Target Raised to $120.00/Share From $115.00 by Piper Sandler
Dow Jones·10/19 16:31
BridgeBio Pharma Is Maintained at Overweight by Piper Sandler
TipRanks·10/19 12:35
BridgeBio Pharma price target lowered to $102 from $104 at BofA
Same Industry
Name/Symbol
Change%
Price